Rechercher dans ce blog

Wednesday, August 31, 2022

Canada's monkeypox outbreak showing 'downward trend,' WHO head says - CBC News

Canada's "sustained, downward trend" of monkeypox cases is "encouraging" to see, as several countries in the Americas deal with increasing numbers of infections, the head of the World Health Organization said Wednesday. 

"In the Americas, which accounts for more than half of reported cases, several countries continue to see increasing numbers of infections, although it is encouraging to see a sustained downward trend in Canada," said Dr. Tedros Adhanom Ghebreyesus, director-general of the World Health Organization, said at a press conference in Geneva.

Some European countries like Germany and the Netherlands are also seeing a "clear slowing" of the monkeypox outbreak, he added.

He says the drop in cases demonstrates "the effectiveness of public health interventions" as well as the tracking of infections and prevention of transmission. 

"These signs confirm what we have said consistently since the beginning: That with the right measures, this is an outbreak that can be stopped," the director-general said.

"And in regions that do not have animal to human transmission, this is a virus that can be eliminated."

Canada has a total of 1,228 monkeypox cases, with the bulk of them in Ontario and Quebec, but the rate in which cases have been spreading has slowed in recent weeks, with just 169 cases reported since Aug. 12. 

Chief Public Health Officer Dr. Theresa Tam hasn't commented on the monkeypox outbreak since Aug. 12, when she said it was "too soon to tell" if cases were slowing here, adding there may be "some early signs" that they are not increasing at the same rate as during the beginning of the outbreak.

WATCH | WHO says Canada's monkeypox outbreak is slowing down

Tam also said Canada will soon move to testing wastewater in different regions of the country to better track the spread of the disease, building off infrastructure developed to monitor COVID-19 during the pandemic. 

WHO Regional Director for Europe Hans Kluge said during a news conference Tuesday that it is possible to eliminate the monkeypox outbreak in Europe, highlighting evidence that case counts are slowing in a handful of countries.

There are encouraging signs of a sustained week-on-week decline in the onset of cases in many European countries, including France, Germany, Portugal, Spain and Britain, as well as a slowdown in some parts of the United States, despite scarce vaccine supplies.

"We believe we can eliminate sustained human-to-human transmission of monkeypox in the [European] region," Kluge said. "To move towards elimination…we need to urgently step up our efforts."

The number of monkeypox cases reported globally also dropped by 21 per cent last week, reversing a month-long trend of rising infections and a possible signal the outbreak in Europe may be starting to decline, according to a WHO report released on Aug. 25.

The WHO reported 5,907 new weekly cases and said two countries, Iran and Indonesia, reported their first cases last week. To date, more than 46,000 cases have been reported in 98 countries since late April.

Adblock test (Why?)


Canada's monkeypox outbreak showing 'downward trend,' WHO head says - CBC News
Read More

A new report suggests a few drinks aren’t as harmless as we thought | The Current with Matt Galloway | Live Radio - CBC.ca

A new report suggests having more than six drinks per week leads to an increased risk of health issues, including cancer. The Canadian Centre on Substance Use and Addiction (CCSA) also found drinking more was even riskier for women. Guest host Susan Bonner talks with Dr. Peter Butt, co-chair of the expert panel developing Canada's new Low-Risk Alcohol Drinking Guidelines, and Dr. Jennifer Wyman, the medical director of Substance Use Service at Women’s College Hospital.

Aired: Aug. 31, 2022

Adblock test (Why?)


A new report suggests a few drinks aren’t as harmless as we thought | The Current with Matt Galloway | Live Radio - CBC.ca
Read More

University of Saskatchewan research project aims to cure HIV - Global News

Public Health Agency of Canada (PHAC) stats show Saskatchewan was the leading province for reported human immunodeficiency virus (HIV) cases, with double the national average in 2020.

Now, the University of Saskatchewan (USask) has received nearly $900,000 of federal funding to not just go ahead with research to combat HIV, but to cure it.

Research lead and assistant professor at the USask’s College of Medicine, Dr. Kerry Lavender (PhD) was also awarded and additional $100,000 in funds for early career investigators with the highest-ranking projects whose research focuses on pandemic preparedness and health emergencies.

Read more: Sask. HIV diagnoses up 18%, syphilis up 172% in 2019

“Currently, the only effective means of treating HIV-1 involves the use of antiretroviral therapy (ART) regimens,” said Lavender. “[Our research is] gonna make a big difference for people who already have HIV, it’s gonna be less scary if you come in contact with it.”

A positive result from the project would also reduce costs and stress on the health-care system, Lavender adds.

According to Smart Sex Resource, out of pocket medication can cost $300-$500 a month per person.

Read more: Antiretroviral drugs stop HIV transmission, study shows — but can people afford them?

“Those drugs are not fun to take, it’s not something you want to do and they’re very very expensive. I mean, our health-care covers them, we’re lucky but it’s a significant cost,” said Lavender.

While just over 70 per cent of newly diagnosed cases were from males, a majority of new cases in males occur from male-to-male sexual contact.

However, injection drug use also makes up for just over 10 per cent in males, and over 30 per cent in females.

Public Health Agency of Canada (PHAC) stats show, Saskatchewan was the leading province for reported human immunodeficiency virus (HIV) cases, with double the national average in 2020.

Elizabeth Plishka with Prairie Harm Reduction said if a cure is found, it would make a huge impact on the health of those in the drug community.

“If you’re someone that, you don’t have that stability, you don’t have a house to keep your meds in, something like that, then it can be really hard to take those meds every single day,” said Plishka.

Read more: Canada announces $17.9M at Montreal AIDS conference to expand HIV testing

Plishka added that some drug users do not have a stable environment to address health concerns.

With all the positives that come along with finding a cure, Vidya Reddy, an educational specialist with the AIDS Programs South Saskatchewan (APSS), said the research could help end the stigma around those who struggle with the virus every day.

“If we do actually find a cure for HIV, we can change all of this overnight,” said Reddy.

Lavender mentioned the research is already underway as she assembles her team with professionals from around the world.

One researcher who is already in the group has come from Japan with previous experience under his belt in the HIV research realm.

Click to play video: 'Canada criticized for higher HIV rates compared to other industrialized countries' Canada criticized for higher HIV rates compared to other industrialized countries
Canada criticized for higher HIV rates compared to other industrialized countries – Jul 29, 2022

© 2022 Global News, a division of Corus Entertainment Inc.

Adblock test (Why?)


University of Saskatchewan research project aims to cure HIV - Global News
Read More

Monkeypox case in child under 4 confirmed by Montreal public health officials - CTV News Montreal

Montreal public health officials confirmed Wednesday one case of monkeypox in a child under the age of four.

Officials say the case was confirmed through two PCR tests at the Quebec Public Health Laboratory, but would not provide further details on the specific case due to privacy concerns.

"To date, worldwide, the majority of cases among children have been acquired through contact within the same household," explains Marianne Paquette, a spokesperson with the Centre intégré universitaire de santé et de services sociaux du Centre-Sud-de-l’Île-de-Montréal. "The epidemiological investigation has been completed for this case, and all necessary interventions to protect the health of the population have been implemented."

Quebec has reported a total of 493 monkeypox cases since the virus made its way to the province.

The Public Health Agency of Canada (PHAC) adds there are 1,228 cases in nine provinces, with 35 hospitalizations and no deaths.

Monkeypox is typically transmitted through close, prolonged contact with an infected person.

Montreal public health officials note people are considered at risk when:

  • their skin or mucous membrane are in direct contact with skin lesions or biological fluids of a positive case;
  • they are in contact with surfaces and objects contaminated by the biological fluids of a positive case;
  • they have face-to-face contact of less than one metre for three or more hours without a procedural mask with a positive case.

Symptoms can include rash, swollen lymph nodes and fever.

Health officials stress that anyone can become infected and transmit the monkeypox virus, and it is not related to sexuality at all. 

Adblock test (Why?)


Monkeypox case in child under 4 confirmed by Montreal public health officials - CTV News Montreal
Read More

Racialized people had higher mortality rates from COVID-19: Statistics Canada - Victoria News

A Statistics Canada study has found that some racialized populations in Canada had significantly higher mortality rates from COVID-19.

The analysis says the COVID-19 death rate was much higher for racialized people compared to non-racialized people. It found 31 deaths per 100,000 for racialized people and 22 deaths per 100,000 for the non-racialized population.

“It confirms what a lot of us had believed, how COVID has basically targeted racialized people,” said Dr. Anna Banerji, an infectious disease specialist and a professor at the Dalla Lana School of Public Health at the University of Toronto.

Black people had the highest mortality rate — more than two times higher than non-racialized residents. That was followed by those who identify as South Asians and Chinese.

However, those who were Chinese had a similar mortality rate to non-racialized people.

The study estimated COVID-19 mortality rates in Canada in 2020 and compared them with newly released census data from 2016. Only South Asian, Chinese and Black people were analyzed due to sample size restrictions, the study said.

Nicole Aitken, an analyst with Statistics Canada in Ottawa, said the findings were limited because researchers did not have data on people living in care homes or other institutional living arrangements. In the early stage of the pandemic, there were deadly outbreaks in care homes across the country.

The study also did not include the effect of COVID-19 vaccines, which were widely distributed starting in 2021.

The study found that across the Canadian population, men had higher mortality rates, but Black men were the highest at 62 deaths per 100,000 people. Black women also had a much higher mortality than their non-racialized counterparts.

Chinese women had the lowest mortality rate at 16 deaths per 100,000 people.

The study also explored the effects of being low income on the mortality rate for racialized people after accounting for other risk factors such as age, sex and housing type.

The study found a person’s socioeconomic situation played a role in COVID-19 deaths for all populations, except Chinese people.

“The rate for the Black people who were living in low income were almost three times higher compared to the Black people not living in low income,” Aitken said.

“So this group … seems to be in a lot more vulnerable situation than some of the other populations in Canada.”

People in low income, overcrowded housing and apartments had higher odds of dying from COVID-19.

Banerji said it’s clear that a lot of racialized people are at increased risk due to poverty and underlying disease. She added that a lot of them were also in front-line, low-paying jobs where they were unable to stay at home or take sick days.

“This kind of data helps us with public health policy that recognizes the disparity and tries to address it,” she said.

David Fisman, a professor of epidemiology at the University of Toronto, said it is important race and ethnicity are taken seriously as factors in people’s health. He said that data hasn’t been available in Canada until recently.

“There’s this interaction between Black race-ethnicity in Canada and low income that is just deadly to people,” Fisman said.

“When you have Black race-ethnicity and you are also impoverished, that seems to confer a tremendously high risk.”

The study said its findings were consistent with others conducted in the United States and elsewhere which found more severe outcomes among racialized populations.

A study commissioned by the Black Coalition Against COVID in the U.S. found rates of infection, hospitalization and death were highest among Black Americans. That study said it was a result of structural and societal realities, including working front-line jobs, living in multi-generational homes and in more populated areas. Health inequalities, including higher rates of diabetes and chronic kidney disease, as well as racism and bias within the health-care system also play a role, that study said.

The Statistics Canada study said the relationship between low income, racialized populations and COVID-19 mortality could be explained by “multiple pathways.” Low income, unsuitable housing and less access to preventive health care can increase risk.

Fisman said the results may not be surprising for people who saw mass spreading of the virus in low-income neighbourhoods or at work places that are poorly ventilated.

He said it shows how clean indoor air is an important health equity issue.

“It’s getting easier and easier to see what the mechanisms are that are driving these disparities,” he said. “A lot of it simply relates to where people live and work and spend time indoors.”

The study did not analyze the effect of COVID-19 on Indigenous people due to data limitations.

Race-based COVID-19 data released in Manitoba last year showed Indigenous people made up 17 per cent of COVID-19 infections, despite making up 13 per cent of the provincial population. The First Nations COVID-19 task force in the province found much higher rates of severe outcomes and death among that population throughout the pandemic.

Kelly Geraldine Malone, The Canadian Press

Like us on Facebook and follow us on Twitter.

COVID-19

Adblock test (Why?)


Racialized people had higher mortality rates from COVID-19: Statistics Canada - Victoria News
Read More

Montreal public health probing 'probable' monkeypox case involving child - Kitchener.CityNews.ca

Montreal public health officials are investigating a probable case of monkeypox involving a child.

A spokeswoman for the city's public health department says the "probable case" involves a child four years old or younger.

The agency did not provide any details on the case or the child's condition.

As of today, Quebec is reporting a total of 493 monkeypox cases in the province.

In its last update Friday, the Public Health Agency of Canada reported 1,228 cases spread across nine provinces, with 35 hospitalizations and no deaths. 

Monkeypox spreads when people have close, physical contact with an infected person's lesions, their clothing or bedsheets, and symptoms can also include rash, swollen lymph nodes and fever.

This report by The Canadian Press was first published Aug. 30, 2022.

The Canadian Press

Adblock test (Why?)


Montreal public health probing 'probable' monkeypox case involving child - Kitchener.CityNews.ca
Read More

Maternal COVID-19 Vaccination: Lower Risk for Hospitalization in Infants - The Cardiology Advisor

In infants younger than 6 months of age, maternal immunization with 2 doses of an mRNA SARS-CoV-2 vaccine is associated with a reduced risk for hospitalization for COVID-19, including critical illness, although the reductions were less evident when the omicron variant was predominant. These findings were published in The New England Journal of Medicine.

A case-control, test-negative design was used to evaluate the effectiveness of maternal vaccination for COVID-19 among infants younger than 6 months who had been hospitalized for suspected SARS-CoV-2 infection between July 1, 2021, and March 8, 2022. Infants who were hospitalized with COVID-19 (case infants) and infants with Covid-19-associated symptoms who had a negative SARS-CoV-2 reverse-transcriptase–polymerase-chain-reaction or antigen test (control infants) were included in the study. All of the enrollees had been hospitalized at 30 pediatric hospitals in 22 states in the United States.

Researchers sought to assess the extent to which transplacental transfer of antibodies against SARS-CoV-2 infection following maternal vaccination may confer protection against COVID-19 in infants. They estimated vaccine effectiveness by comparing the odds of full maternal vaccination (2 doses of an mRNA vaccine) among case infants and control infants during circulation of the B.1.617.2 (delta) variant between July 1, 2021 and December 18, 2021, and the B.1.1.259 (omicron) variant between December 19, 2002, and March 8, 2022.


Continue Reading

The researchers enrolled a total of 537 case infants (181 of whom had been admitted during the period of delta variant circulation) and 512 control infants (median age of 2 months in both cohorts). Overall, 16% of the case infants and 29% of the control infants had been born to mothers who were fully vaccinated against SARS-CoV-2 during their pregnancy.

In all, 21% of the case infants needed to receive intensive care, with 12% requiring mechanical ventilation or vasoactive infusions. Among the case infants, 2 died from COVID-19, with neither of these infant’s mothers having been vaccinated during pregnancy.

The effectiveness of maternal vaccination against COVID-19 hospitalization was 52% (95% CI, 33%-65%) overall, 80% (95% CI, 60%-90%) in the period during which the delta variant was circulating, and 38% (95% CI, 8%-58%) during the period of omicron circulation.

The effectiveness against COVID-19-associated hospitalization for either variant among infants was 69% (95% CI, 50%-80%) when maternal vaccination took place after 20 weeks of pregnancy, compared with 38% (95% CI, 3%-60%) when maternal vaccination occurred during the initial 20 weeks of pregnancy. In a similar fashion, during both the delta-predominant period and the omicron-predominant period, the point estimates were higher when maternal vaccination took place after 20 weeks of pregnancy vs during the initial 20 weeks of pregnancy.

Limitations of the study include that the researchers are unable to evaluate potential biases associated with natural SARS-CoV-2 infection before or during pregnancy. Further, the possibility of residual confounding resulting from differences between case infants and control infants cannot be excluded from the analysis. Additionally, the findings from the study might not apply to less severe cases of COVID-19 or to other variants.

“These findings provide additional support for the current recommendations regarding Covid-19 vaccination during pregnancy,” the researcher wrote.

Disclosure: Some of the study authors have declared affiliations with biotech, pharmaceutical, and/or device companies. Please see the original reference for a full list of authors’ disclosures. 

Reference

Halasa NB, Olson SM, Staat MA, et al; Overcoming Covid-19 Investigators. Maternal vaccination and risk of hospitalization for Covid-19 among infants. N Engl J Med. Published online June 22, 2022. doi:10.1056/NEJMoa2204399

Adblock test (Why?)


Maternal COVID-19 Vaccination: Lower Risk for Hospitalization in Infants - The Cardiology Advisor
Read More

Proposed alcohol guidelines highlight health risks with just a few drinks per week - The Peterborough Examiner

A proposed overhaul of Canada’s decade-old drinking guidelines warns of increased health risks from as few as three drinks per week and calls for mandatory labelling of all alcoholic beverages.

In its suggested update to Canada’s Low-Risk Alcohol Drinking Guidelines, the Canadian Centre on Substance Use and Addiction eschews offering a specific daily or weekly limit in favour of outlining a continuum of risk and urging “less is better.”

The Ottawa-based centre says risk is negligible-to-low for two drinks per week, moderate for three-to-six drinks per week and increasingly high beyond that.

It’s a stark shift from current guidelines that were released in 2011, which limit alcohol use to 10 drinks a week for women and 15 drinks a week for men.

But the CCSA says a review of more than 5,000 peer-reviewed studies shows that even very small amounts of alcohol can be harmful, with alcohol now recognized as a risk factor for an increasing number of diseases.

The CCSA says that includes at least seven types of cancer, with alcohol to blame for nearly 7,000 cases of cancer deaths each year. It says most cases are breast or colon cancer, followed by cancers of the rectum, mouth and throat, liver, esophagus and larynx.

The report, published Monday, also dispels the notion that drinking in moderation protects against heart disease, pointing to recent research that found drinking a little alcohol neither decreases nor increases the risk and that at higher levels, alcohol is a risk factor for most types of cardiovascular disease.

The CCSA notes that a significant proportion of alcohol-attributable deaths in Canada were among people following the 2011 guidelines.

The CCSA opened online public consultations this week on the report. The survey is open until Sept. 23 to members of the public as well as any experts with suggestions on additions or clarifications.

Dr. Peter Butt, co-chair on the project, says the finalized guidance is set for release Nov. 15.

The report stresses that all levels of alcohol consumption are associated with some risk.

“It is not lost on the experts that this new Guidance on Alcohol and Health, which puts forward a continuum of risk, will be surprising and unsettling to large segments of the population, including the alcohol industry, media and policymakers,” says the report.

“However, people living in Canada have a right to know. Alcohol is a carcinogen related to at least seven types of cancer, including common ones like colon and breast cancer. Furthermore, in contrast to common perceptions, current evidence shows that drinking a little alcohol does not decrease the risk of heart disease.”

The report also calls on Health Canada to require labels on alcoholic beverages that list the number of standard drinks each contains, pointing to research that suggests Canadians have a limited understanding of what constitutes a standard drink.

Currently, containers must display their alcohol percentage by volume but this doesn’t help people adhere to advice that is based on the number of drinks one might have, says the report.

“The inconsistency in messaging causes consumer confusion and creates barriers for consumers to adhere to alcohol guidance,” it says.

The report also notes that men’s drinking causes disproportionately more injuries, violence and deaths than women’s drinking.

However the risks to women’s health increase more sharply than for men above low levels of consumption.

The report goes well beyond examining alcohol’s health risks by also touching on questions around mental and social harms, including intimate partner violence and sexual violence.

The authors note that it likely requires broader societal and policy changes in order for Canadians to heed advice to drink less, calling for “a cultural shift.”

“Therefore, a corollary to the current project is the requirement for governments to design a healthier environment that will help people make difficult decision making about alcohol a little easier.”

This report by The Canadian Press was first published Aug. 30, 2022.

Adblock test (Why?)


Proposed alcohol guidelines highlight health risks with just a few drinks per week - The Peterborough Examiner
Read More

Racialized people had higher mortality rates from COVID-19: Statistics Canada - Ottawa.CityNews.ca

A Statistics Canada study has found that some racialized populations in Canada had significantly higher mortality rates from COVID-19.

The analysis says the COVID-19 death rate was much higher for racialized people compared to non-racialized people. It found 31 deaths per 100,000 for racialized people and 22 deaths per 100,000 for the non-racialized population.

Black people had the highest mortality rate — more than two times higher than non-racialized residents. That was followed by those who identify as South Asians and Chinese.

However, those who were Chinese had a similar mortality rate to non-racialized people.

The study estimated COVID-19 mortality rates in Canada in 2020 and compared them with newly released census data from 2016. Only South Asian, Chinese and Black people were analyzed due to sample size restrictions, the study said.

Chinese women had lowest mortality rate, data shows

Nicole Aitken, an analyst with Statistics Canada in Ottawa, said the findings were limited because researchers did not have data on people living in care homes or other intuitional living arrangements. In the early stage of the pandemic, there were deadly outbreaks in care homes across the country.

The study also did not include the effect of COVID-19 vaccines, which were widely distributed starting in 2021.

The study found that across the Canadian population, men had higher mortality rates, but Black men were the highest at 62 deaths per 100,000 people. Black women also had a much higher mortality than their non-racialized counterparts.

Chinese women had the lowest mortality rate at 16 deaths per 100,000 people.

The study also explored the effects of being low income on the mortality rate for racialized people after accounting for other risk factors such as age, sex and housing type.

The study found a person’s socioeconomic situation played a role in COVID-19 deaths for all populations except Chinese people.

“The rate for the Black people who were living in low income was almost three times higher compared to the Black people not living in low income,” Aitken said.

“So this group … seems to be in a lot more vulnerable situation than some of the other populations in Canada.”

People in low-income, overcrowded housing more likely to die from COVID-19 

People in low-income, overcrowded housing and apartments had higher odds of dying from COVID-19. Aitken said when more people are grouped together, there’s more possibility for transmission.

The study said its findings were consistent with others conducted in the United States and elsewhere, which found more severe outcomes among racialized populations.

A study commissioned by the Black Coalition Against COVID in the U.S. found rates of infection, hospitalization and death were highest among Black Americans.

That study said it was a result of structural and societal realities, including working front-line jobs, living in multi-generational homes and in more populated areas.

Health inequalities, including higher rates of diabetes and chronic kidney disease, as well as racism and bias within the healthcare system, also play a role, that study said.

The Statistics Canada study said the relationship between low income, racialized populations and COVID-19 mortality could be explained by “multiple pathways.” Low income, unsuitable housing and less access to preventive health care can increase risk.

The study did not analyze the effect of COVID-19 on Indigenous people due to data limitations.

Race-based COVID-19 data released in Manitoba last year showed Indigenous people made up 17 per cent of COVID-19 infections, despite making up 13 per cent of the provincial population.

The First Nations COVID-19 task force in the province found much higher rates of severe outcomes and death among that population throughout the pandemic.

This report by The Canadian Press was first published Aug. 30, 2022.

Adblock test (Why?)


Racialized people had higher mortality rates from COVID-19: Statistics Canada - Ottawa.CityNews.ca
Read More

Tuesday, August 30, 2022

School return should be with minimal disruptions, regional health units say - The Kingston Whig-Standard

Article content

Kingston, Frontenac and Lennox and Addington Public Health and Hastings Prince Edward Public Health said Monday in a joint statement that there should be minimal disruption during the return to school for students and educators.

“As local students prepare to return to the classrooms in September, we anticipate that the 2022-2023 school year will proceed with minimal disruptions. Classroom learning continues to offer the best educational, social and emotional experiences for children and youth, and we are encouraged that many activities such as clubs, groups and sport teams will take place this year. Students are encouraged to get involved and participate in extracurricular activities to discover what interests them. These activities are beneficial for students’ physical, social and mental health,” health unit officers said.

Advertisement 2

Article content

“As with any time of transition, the return to school may be stressful for some families and students. All of us — including our youngest residents — have been through a lot over the past few years. Students may require more support as they return to the classroom. While family support is essential to help students identify and respond to stress, additional supports are also available. Find information on our agencies’ websites or ask your student’s school about any in-school support that might be available.”

While there continues to be a risk of COVID-19, as with other infectious illnesses, families and educators must all work together to keep the risk as low as possible. We must continue to follow these practical public health measures to limit the spread of COVID-19 in schools, the health units stated.

Advertisement 3

Article content

The health units urged parents to screen for illness each school day and stay home (or keep your child home) if sick. If anyone has symptoms of COVID-19, even mild ones, they should stay home. This will help prevent the spread of COVID-19, as well as other infectious illnesses. Follow instructions provided on the school screening tool, and additional guidance is available at www.Ontario.ca/exposed regarding isolation and/or masking requirements.

Check your students’ vaccination records and keep them up to date. Up-to-date vaccination records for regular childhood vaccines are required for students attending school in Ontario. Due to COVID-19-related closures and service delays, many children and youth are not up to date on their regular vaccines. Regular childhood vaccines prevent diseases such as polio, diphtheria, measles, pertussis, hepatitis B and more. Protect your child from these preventable illnesses by keeping their routine vaccines up to date.

Advertisement 4

Article content

Get your child caught up on their routine childhood vaccines by booking an appointment with your health-care provider or at local public health’s routine immunization clinics.

Parents and guardians are responsible for reporting their child’s vaccinations to public health.

Stay up to date with your COVID-19 vaccinations. Children and youth six months of age and over are now eligible for COVID-19 vaccinations, and youth 12 to 17 years of age are eligible for a booster dose six months after their second dose. Vaccinations continue to be the most effective way to limit the spread of COVID-19 and reduce the severity of illness associated with the virus. Public health continues to offer COVID-19 vaccination clinics, which are posted on their websites.

Advertisement 5

Article content

As we learn to live with COVID-19, school communities will continue to support healthy and safe classrooms and reduce the spread of illness through enhanced cleaning, absence monitoring, hand hygiene and respiratory etiquette and ventilation best practices. Public health will support these efforts and continue to work with school communities to improve the health and well-being of students and staff through provision of health promotion resources, curriculum supports, home-school communications resources and in-person clinical services in schools.

Together with their school community partners, local public health units look forward to welcoming students back to school this September. As we learn to live with COVID-19, public health urges people to continue to take reasonable and responsible steps to keep themselves, their family, their community and their schools healthy and safe.

    Advertisement 1

    Adblock test (Why?)


    School return should be with minimal disruptions, regional health units say - The Kingston Whig-Standard
    Read More

    Monday, August 29, 2022

    Why clean air might be for the 21st century what clean drinking water was for the 19th - TVO Today

    [unable to retrieve full-text content]

    Why clean air might be for the 21st century what clean drinking water was for the 19th  TVO Today
    Why clean air might be for the 21st century what clean drinking water was for the 19th - TVO Today
    Read More

    UBC In The News - UBC News

    Yeast experiments on Artemis 1 may help astronauts survive cosmic radiation in deep space

    Pharmaceutical sciences professor Dr. Corey Nislow is sending yeast and algae cultures into space through NASA’s Artemis 1 lunar mission.
    CBC via Yahoo, Canadian Press via CastanetCalgary HeraldCKPG TodayRMOToday.comCHVN 95.1FMToronto Star via St. Catharines Standard

    Adblock test (Why?)


    UBC In The News - UBC News
    Read More

    Sunday, August 28, 2022

    Province expands eligibility for monkeypox vaccine - mySteinbach.ca

    Manitoba Health has announced that it is expanding eligibility for the monkeypox vaccine for pre-exposure prophylaxis effective August 29, 2022. Eligibility includes:

    • cisgender, transgender or two-spirit people who self-identify as belonging to the gay, bisexual and other men who have sex with men (gbMSM) community and who meet at least one of the following criteria: have received a diagnosis of a sexually transmitted infection in the past six months (previously, was a diagnosis of chlamydia, gonorrhea or syphilis in the past two months); have had two or more sexual partners in the last 90 days (previously, was in the past 21 days); have had anonymous sex in the past 90 days (e.g. using apps, online sites, formal/informal gatherings) or are planning to (previously, was in the past 21 days);have attended locations for sexual contact (e.g. bath houses or sex clubs) or are planning to; engaged in sex work or plan to, as a worker or client; or
    • any sexual contacts of the individuals described above (new).

    Newly eligible individuals will be able to begin booking vaccination appointments on Monday, Aug. 29 at 9 a.m.

    Anyone can become infected with monkeypox. However, in Canada and around the world, at this time infections have been primarily reported among people who self-identify as belonging to the gbMSM community.

    Manitoba has reported one confirmed case of monkeypox to date.

    As of Aug. 21, 436 doses of the vaccine have been administered to eligible people in Manitoba. This information is updated online on Tuesdays, based on information entered in the provincial immunization registry. The registry is routinely updated by health-care providers, but is not intended to provide real-time data.

    Appointments are available in communities across the province. Preventive immunization for eligible people can be booked using the online booking tool at patient.petal-health.com. People who do not have internet access can call Health Links-Info Santé at 204-788-8200 or (toll-free) at 1-888-315-9257 for assistance booking appointments.

    Public health will also be reaching out to eligible populations to support immunization efforts. If appointments in the online system are not easily accessible, individuals can also contact their local public health office to discuss other options.

    Individuals who are a close contact to someone with monkeypox continue to be eligible for post-exposure vaccination and should contact their local public health office to make an appointment.

    People who need more information about monkeypox or immunizations can contact their local public health office, their health-care provider or Health Links-Info Santé. Additional information is also available at gov.mb.ca.

    Adblock test (Why?)


    Province expands eligibility for monkeypox vaccine - mySteinbach.ca
    Read More

    Bats discovered in proposed Archibald Lake wilderness area - CBC.ca

    Bats are now one of the many rare species observed living in Nova Scotia's Archibald Lake wilderness area.

    The discovery was made by retired biologist Edwin DeMont.

    He picked up on bats using a device that can record the ultrasonic frequencies bats use to echolocate. 

    DeMont tweeted about the discovery on Aug. 21, saying he was working to identify which species of bat he had found. 

    He thinks it's a little brown bat, one of the three species of bats considered endangered in Nova Scotia.

    "What we're hoping for is that the provincial government is going to designate and protect the Archibald Lake wilderness area and we're trying to keep increasing the numbers of rare species we identify there," DeMont said.

    No timeline for decision on Archibald Lake

    DeMont works with the St. Mary's River Association, a conservation group based in Sherbrooke, N.S., that has been trying to get Archibald Lake protected since 2019.

    The association is worried the Cochrane Hill gold project, a proposal to build an open-pit gold mine in the area, could have negative impacts on local ecosystems. 

    The former Liberal government considered Archibald Lake for protection in 2020. Current environment minister Tim Halman told CBC in July that no decision had been made regarding the designation of the area. 

    St. Mary’s River Association has been trying to get Archibald Lake protected since 2019. (Canadian Parks and Wilderness Society)

    Scott Beaver, president of the river association, said in a statement that his team has been meeting with local politicians to raise awareness about the importance of the wilderness area. 

    He said the organization hasn't had as much luck meeting with senior officials from the province.

    Bat conservation in Atlantic Canada

    Bat populations in Nova Scotia declined severely in the early 2010s with the onset of white-nose syndrome. The fungal disease had taken out about 95 per cent of the province's bat population by 2013, according to the Mersey Tobeatic Research Institute.

    The institute is a major player in bat conservation in Nova Scotia. It works with the Nova Scotia Department of Natural Resources and Renewables and the North American Bat Monitoring Program to research and monitor bat populations.

    Lori Phinney, the leader of the institute's bat project, said in a statement that bats are critical to Canadian ecosystems and agriculture because of pest control.

    "All the bats native to Canada and Nova Scotia are insect eaters and one little brown bat can eat hundreds to thousands of insects in one night," Phinney said. "Their worldwide value as a natural form of pest control for agriculture and forestry is estimated in the billions of dollars."

    Lori Phinney, left, does bat research at one of Nova Scotia’s surviving bat colonies. (Submitted by Lori Phinney)

    Most bats can only have one baby per year. That is partly why bat populations are still struggling to recover. 

    Phinney said there are about 15 known sites of little brown bat colonies in southwest Nova Scotia. While this is nowhere near the amount a healthy population should have, the number of bats in these colonies has been increasing in recent years.

    "We hope this is a promising sign there are more bats and also bats who can cope with the impacts of the disease white-nose syndrome," Phinney said.

    Phinney encourages Nova Scotians to keep an eye out for bats and report any sightings. Reports can be made online at www.batconservation.ca.

    MORE TOP STORIES 

    Adblock test (Why?)


    Bats discovered in proposed Archibald Lake wilderness area - CBC.ca
    Read More

    Saturday, August 27, 2022

    Bird found in Bradford West Gwillimbury tests positive for West Nile virus - thepeakfm.com

    The Simcoe Muskoka District Health Unit (SMDHU) is warning residents after a bird found dead in Bradford West Gwillimbury tested positive for West Nile.

    The health unit said this is the first lab-confirmed evidence of West Nile in Simcoe Muskoka this year.

    “As of Aug. 25, no human cases of the mosquito-borne viral disease have been reported in Ontario in 2022,” the health unit said in a news release.

    According to the SMDHU, West Nile circulates between some species of mosquitoes and birds.

    Read more:

    Mosquitoes in Peterborough test positive for West Nile virus: health unit

    It can also be transmitted to humans through a mosquito bite, if the mosquito had bitten an infected bird.

    “Finding this infected bird is a reminder that we need to continue to take appropriate measures to protect ourselves against West Nile virus at this time of year,” Brenda Armstrong, program manager of SMDHU’s healthy environment program said in the release.

    “The best way for the public to protect themselves is to prevent mosquito bites.”

    According to the SMDHU, the risk of contracting the virus from a mosquito is highest in the late summer.

    The health unit said while most people will not become sick if they are bitten by an infected mosquito, the virus can cause severe illness in some.

    “Symptoms of WNv include fever, muscle weakness, stiff neck, confusion, severe headache and a sudden sensitivity to light. In very rare cases, the virus may cause serious neurological illness,” the release said. “Those experiencing symptoms should seek medical advice.”

    Read more:

    Hamilton raises West Nile virus risk assessment after batch of mosquitoes test positive

    The health unit also said there are a few “personal protection measures” that can be taken.

    People should use an approved mosquito repellent, wear light-coloured clothing and should cover up when mosquitoes are present.

    People should also stay indoors when mosquitoes are most active, such as at dusk and dawn, the health unit said.

    © 2022 Global News, a division of Corus Entertainment Inc.

    Adblock test (Why?)


    Bird found in Bradford West Gwillimbury tests positive for West Nile virus - thepeakfm.com
    Read More

    Manitoba Expands Monkeypox Vaccine Eligibility - ChrisD.ca

    August 26, 2022 4:07 PM | News


    Monkeypox Vaccine

    Registered pharmacist Sapana Patel holds a bottle of monkeypox vaccine at a pop-up monkeypox vaccination site on Wednesday, Aug. 3, 2022, in West Hollywood, Calif. (AP Photo/Richard Vogel)

    WINNIPEG — Manitoba has expanded eligibility for the monkeypox vaccine for pre-exposure prophylaxis.

    The eligibility for those able to receive the vaccine takes effect Monday, August 29 and includes:

    • Cisgender, transgender or two-spirit people who self-identify as belonging to the gay, bisexual and other men who have sex with men (gbMSM) community and who meet at least one of the following criteria
    • Have received a diagnosis of a sexually transmitted infection in the past six months (previously, was a diagnosis of chlamydia, gonorrhea or syphilis in the past two months)
    • Have had two or more sexual partners in the last 90 days (previously, was in the past 21 days);
    • Have had anonymous sex in the past 90 days (e.g. using apps, online sites, formal/informal gatherings) or are planning to (previously, was in the past 21 days);
    • Have attended locations for sexual contact (e.g. bath houses or sex clubs) or are planning to;
    • Engaged in sex work or plan to, as a worker or client; or
    • Any sexual contacts of the individuals described above (new).

    Newly eligible individuals will be able to begin booking vaccination appointments at 9 a.m. on Monday.

    Manitoba has reported one confirmed case of monkeypox to date.


    Adblock test (Why?)


    Manitoba Expands Monkeypox Vaccine Eligibility - ChrisD.ca
    Read More

    No deaths as recent Kent Institution COVID-19 outbreak ends - Agassiz Harrison Observer

    A small outbreak of COVID-19 among inmates at Kent Institution is now over.

    As of Aug. 24, there are no active cases of COVID-19 at the maximum security institution, according to data from Correctional Service Canada (CSC). There were nine inmates who were infected in an outbreak that began on July 29. The last inmate recovered on Aug. 21.

    There has been a total of 112 inmates infected with COVID-19 in two separate outbreaks at Kent Institution. More than 900 COVID-19 tests have been recorded to date among the inmate population.

    There have been no deaths associated with any outbreak at Kent Institution. Nationwide, there have been 6,253 cases of COVID-19 among inmates. Of those, six have died as of Aug. 24.

    All CSC staff are provided with personal protection equipment, including medical masks, respirators and face shields. Inmates are also provided medical masks and asked to wear them at all times when not in their cells. Enhanced cleaning and disinfecting procedures remain in place.

    34.4 per cent of Kent Institution inmates are fully vaccinated with a booster; 65.2 per cent have received two doses of the COVID-19 vaccine, and 68.3 per cent have received at least one dose.

    Mountain Institution has seen 134 cases of COVID-19 to date. 68 per cent of inmates there are fully vaccinated with a booster, while 85 per cent have received two doses of the vaccine and 88.5 per cent have received at least one dose. At Kwìkwèxwelhp Healing Lodge, there have been only 10 cases of COVID-19 reported since the beginning of the pandemic. All inmates at the healing lodge have received two doses of the COVID-19 vaccine, while 90.9 per cent have received one booster dose.

    Anyone entering correctional facilities is screened for COVID-19.

    agassiz

    Adblock test (Why?)


    No deaths as recent Kent Institution COVID-19 outbreak ends - Agassiz Harrison Observer
    Read More

    Combination 'polypill' lowers the risk of major cardiovascular events, study finds - CTV News

    Older heart disease patients who took a combination "polypill" made up of three different medications had a lower risk of major cardiovascular events, according to a new study published Friday in the New England Journal of Medicine and presented at the European Society of Cardiology Congress in Spain.

    Study authors led by Dr. Valentin Fuster, director of Mount Sinai Heart in New York City and general director of the Spanish National Center for Cardiovascular Research, looked at 2,499 patients in seven European countries who had a history of type 1 myocardial infarction in the past six months and were either over the age of 75 or a minimum age of 65 with at least one risk factor, such as diabetes or mild or moderate kidney dysfunction.

    Half the patients were given the polypill that contained aspirin, ramipril and atorvastatin, while others received the usual standard of care. Patients were followed for a median of three years.

    The researchers found 48 cardiovascular deaths in the polypill group and 71 in the usual-care group, meaning patients who took the polypill had a relative risk reduction of 33% for cardiovascular death. The polypill was also favorable in other measures studied in the trial, such as stroke or myocardial infarction.

    The polypill and trial come after 15 years of work, Fuster said. He and colleagues decided that one of the main problems in medicine is the lack of adherence to the medication they're meant to be taking, particularly in the cardiovascular field and most specifically in heart attack patients.

    The American Heart Association lists taking medications as prescribed as one of the first things people can do to prevent another heart attack after having one.

    "It seems that we have a tremendous kind of tool, which is a simple polypill, that actually is significantly better," Fuster said. "Probably most of the reason is because of better adherence, because it's a simple drug, with superb results and the impact is as good or even better than aspirin in the past."

    He said it was notable that the two curves -- those who took a polypill and those who received standard care -- separated from the beginning and continued to separate as the years go on, meaning there is a feeling that is the study went longer there would be "even more striking" results.

    Fuster said that the polypill is something that could have a "very significant" impact on the general population.

    According to the U.S. Centers for Diseases Control and Prevention, someone in the US has a heart attack every 40 seconds. There are around 805,000 heart attacks in the country every year -- 200,000 of those happening to people who have already had one.

    There are some limitations to the research, including that the trial was not performed in a blinded manner and all patients were enrolled before the COVID-19 pandemic.

    Adblock test (Why?)


    Combination 'polypill' lowers the risk of major cardiovascular events, study finds - CTV News
    Read More

    Friday, August 26, 2022

    Meningococcal disease: What to know about the infection - CP24

    As Canada’s health care system struggles amid health-care worker shortages and burnout while Canadians continue to deal with the threat of COVID-19 and monkeypox, the news of another disease forming a potential threat has sparked questions and concerns among Canadians.

    On Thursday, the City of Toronto declared an outbreak of meningococcal disease after one person has died and two others remain infected.

    But what is this life-threatening disease and what tools do we have to face it? Here’s what we know about the infection.

    WHAT IS IT?

    Meningococcal disease refers broadly to illnesses caused by a specific bacterium called Neisseria meningitidis, sometimes just referred to as the meningococcal bacterium.

    These illnesses can include meningitis, an inflammation of the fluid around the brain and spinal cord. It can also result in septicemia, a serious form of sepsis in which the blood is infected.

    Not all types of meningitis are caused by meningococcal disease, as it can be caused by several different types of bacterial infection, viral infections or even a fungal infection, in rare cases.

    The presentation of invasive meningococcal disease can vary depending on if it progresses to meningitis or septicemia, but all forms of meningococcal disease are an emergency, and require immediate medical attention.

    Around one in 10 people who contract meningococcal disease will die, and up to a fifth of survivors may have long-term disabilities, including brain damage, deafness or loss of limbs, according to the U.S. Centers for Disease Control (CDC).

    Meningococcal disease is endemic in Canada, which means that outbreaks do occur from time to time, although they are rare, with the incidence rate varying across the country.

    Between 2012 and 2019, the average incidence rate nationally was 1 case per 290,000 people. According to Health Canada, the most recent documented outbreak was in 2017 among five adolescents in B.C. 

    HOW DOES IT SPREAD AND HOW INFECTIOUS IS IT?

    Meningococcal disease is spread through close contact with the saliva of others through activities such as kissing, coughing or sneezing as well as sharing items that are inserted into the mouth such as toothbrushes, cigarettes, mouth guards, chapstick or lipstick or musical instruments performed using the mouth.

    Around one in ten people are carriers of the meningococcal bacterium, meaning they unknowingly have it in their nose and throat without becoming ill themselves.

    The meningococcal bacterium is far less transmissible than the virus than causes COVID-19 — you cannot contract meningococcal disease purely from breathing the same air as someone carrying the bacteria.

    It also is more difficult to transmit than the common cold or flu, according to the CDC, and a person generally needs close and lengthy contact with a patient to contract it.

    When a person contracts the disease, their family members, roommates and romantic partners are more at risk of also contracting it.

    HOW DO YOU KNOW IF YOU HAVE IT?

    A person who has contracted the disease will begin experiencing symptoms in two to 10 days after exposure, with most symptoms appearing within three to four days, according to Health Canada.

    Common symptoms include a sudden fever, headache and a stiff neck for those with meningococcal meningitis, potentially accompanied by vomiting, light sensitivity and confusion.

    For those with septicemia caused by meningococcal disease, symptoms can include fever and chills, vomiting, fatigue, cold hands and feet, muscle aches and diarrhea.

    In later stages, meningococcal septicemia can be accompanied by a fast spreading skin rash that starts as purplish spots.

    Because many of the early symptoms are so similar to other illnesses, the disease has to be diagnosed through laboratory testing, making it important to seek medical attention as soon as you suspect you may have the disease.

    Without treatment, a patient could end up hallucinating, falling into a coma, or even dying.

    HOW IS IT TREATED?

    Those with invasive meningococcal disease are treated with antibiotics for three to seven days. Doctors will issue antibiotics as soon as a person says they suspect they have the disease, even before confirmation, in order to reduce the risk of the illness progressing to fatal.

    If the disease was only caught in the later stages, a person might hospitalization for breathing support, care for skin damaged by a rash or surgery for dead tissue.

    IS THERE A VACCINE?

    There are several vaccines approved for use in Canada which target well-known serogroups of meningococcal disease. The Men-C vaccine protects against type C, the meningococcal quadrivalent vaccine protects against types A, C, Y and W-135, and the Men-B vaccine protects against type B.

    According to the City of Toronto, all three individuals confirmed Thursday to have contracted meningococcal disease had the “same rare strain of serogroup C meningococcal disease.”

    Infants in Canada are able to receive the Men-C vaccine as part of routine immunizations as two doses at 2 months and 12 months.

    Either the Men-C or the quadrivalent vaccine is offered through school immunization programs in all of the provinces and territories in Canada, although the grade at which the vaccine is offered varies from grade 6-12 depending on the region.

    In Ontario and New Brunswick, proof of vaccination against meningococcal disease is required for all school-attending children.

    While many people in Canada will have received vaccination against meningococcal disease through these routine immunizations given to children, large immunization programs to vaccinate against meningococcal disease only became widespread in Canada the early 2000s, although there were several immunization campaigns that launched in the 90s in response to outbreaks in certain provinces.

    This means many adults may have never received a vaccine.

    The City of Toronto on Thursday urged residents to find out if they’ve received the meningococcal vaccine.

    “Adults between 20 and 36 years old who have not received a meningococcal disease vaccine are strongly recommended to contact their health care provider to receive a meningococcal disease vaccine as soon as possible,” the statement reads. “TPH will monitor vaccine demand and is actively exploring additional vaccination channels.”

    Adblock test (Why?)


    Meningococcal disease: What to know about the infection - CP24
    Read More

    Tuberculosis outbreak in Pangnirtung, Nunavut, continues to grow - CBC.ca

    Tuberculosis continues to spread in Pangnirtung, Nunavut, where 161 people have now been diagnosed with active or latent TB since Jan. 1 last year.

    About 1,600 people live in the hamlet. Thirty-five of them have been diagnosed with active TB and 126 with latent TB.

    Latent TB isn't contagious, according to Nunavut's health department, but still needs to be treated to stop it from becoming active.

    The latest numbers, announced Friday morning, represent an increase from three months ago, when 31 people had been diagnosed with active TB and 108 with latent TB.

    Nunavut declared an outbreak of the disease in Pangnirtung on Nov. 25, 2021.

    The health department says anyone exposed to an active case should visit the health centre for screening. They should also get screened if they're showing symptoms of TB.

    Symptoms of active TB include a cough that lasts longer than three weeks, feeling very tired, loss of appetite and a fever or night sweats.

    In the past, the territory has resisted calls to report cases of tuberculosis by community, arguing there's a stigma around the disease.

    Earlier this year, the territory's privacy commissioner said Nunavut needs to be more transparent about the illness and share statistics about which demographics are affected.

    Adblock test (Why?)


    Tuberculosis outbreak in Pangnirtung, Nunavut, continues to grow - CBC.ca
    Read More

    You Likely Have A Doppelgänger And Share Their DNA?! - Feel Good Friday | Sickboy | CBC Podcasts - CBC.ca

    How to Subscribe

    Share Podcast

    Sickboy is determined to break down the stigma associated with illness and disease. Join Jeremie, Brian and Taylor as they tackle health taboos with people who have experienced them firsthand. Taking the lead from Jeremie's life long battle with Cystic Fibrosis, the three best friends help us understand that sometimes the best way to deal with illness, disease and life is simply to laugh.

    Updated: Aug. 26, 2022

    Adblock test (Why?)


    You Likely Have A Doppelgänger And Share Their DNA?! - Feel Good Friday | Sickboy | CBC Podcasts - CBC.ca
    Read More

    Researcher studying life's complexities to improve chronic disease care - STAT

    Having a chronic disease can feel like a full-time job. There are the symptoms, the flare-ups, the medications and therapies and appointments. And there are tiny adjustments to be made all the time — to a sitting position, a meal, a plan, an expectation. 

    And, just like in any job, a person’s ability to do the work required of their chronic disease (or, more likely, their two or more chronic conditions) fluctuates. University of Minnesota researcher Nathan Shippee creates tools that can help providers understand and navigate patient complexity. “How we deliver health care can really either make it a little easier for a person to manage things or a little more difficult,” said Shippee, an associate professor of health policy and management at the university’s public health school. 

    Using a scientific approach, he and his colleagues try to understand the lived experience of patients — and not just in the physical therapist’s suite or the dialysis clinic. STAT spoke with Shippee about his work to capture what’s happening with patients outside the health care system and connect it to their outcomes. This interview has been edited for clarity and brevity. 

    How do you explain what you do to someone at a dinner party or a stranger in line at the supermarket?

    Well, the biggest part of my work is, practically speaking, focused on how we organize and deliver services for people who have physical health, behavioral health — that is, mental or substance use disorders — needs. A lot of times, my work also gets into the area of, “Well, you’ve got those things,” but then on top of that, you often have people who have social factors that also complicate their care. So, really commonly, things like unstable housing and homelessness, for instance. It’s really how we organize and deliver the services. 

    How did you land on this work? 

    When my wife and I moved to Minnesota, I started as a fellow at the Mayo Clinic, working with a doctor named Victor Montori, who is really well-known in the area of patient-centered care for people with chronic diseases, especially. And then as I continued working past the fellowship at the Mayo Clinic, this was just an area that I started focusing on. 

    There’s a topic that we talk about in chronic care called “patient complexity.” And complexity is more than just being complicated; there’s a whole theory around complexity. …So what I and some other scientists have done is really try to say, OK, what if you actually take complexity proper and apply it [to patient care]? 

    And then you start getting into realizing that actually, patients’ lives are made complex by all kinds of systems around them: their family, their work life, their work history, their lived history, and health care, too. How we deliver health care can really either make it a little easier for a person to manage things or a little more difficult. Health care can be accessible and it can be well-designed or it can be less so. And to the degree that it is less so, that means that even if a person really wants to take care of their health, health care is just adding more uncertainty into that person’s life. 

    Does it feel frustrating, knowing there are so many overlapping factors that are so much bigger than what you can address in an encounter with a patient? 

    I’m a Ph.D., so I’ve got the benefit of not actually having to worry about somebody’s life and how I’m helping manage it as if I were a provider. But I do work with a lot of providers. And one of the things that I think is scientifically interesting but also really discouraging is that things don’t always complicate somebody’s life and their care in ways that you would expect from a simple point of view. Some of the things we hear about with people who experience homelessness: they don’t have a place to store their medications.  

    But if you are using the shelter system, typically, you can’t stay there all day, and so you have hours that you need to fill up and also, you need to handle your meals. If somebody is dealing with chronic diseases, like diabetes, for instance, where diet can make a big difference on how well you’re controlling your diabetes, and at the same time, you have little to no income, it’s really hard to eat well. People who have diabetes who experience homelessness are not stupid. They’ve gotten all the patient education materials, and they know that there’s a lot of things that aren’t great for their diet, so you’re adding stress to that person’s life. 

    Why have you decided to focus some of your work on chronic disease?

    Chronic disease, basically by definition, is something you can’t cure. It doesn’t go away. And that means it can be pretty grueling, quite a slog. …If you think about all the people who have chronic diseases, and I mean the most common chronic diseases, multiple chronic conditions — the largest number of people actually have more than one — and how long people live with those conditions, to me that represents a really big challenge. 

    What interests you about end-of-life care? 

    End of life is the culmination of long-standing chronic conditions. There’s been work talking about people living with chronic disease in an “illness career.” This is like retiring from that career. And now we’ve got to say, “Well, right now they’re taking 15 medications, and we think that over the next 2 to 5 years, at most, this person’s probably going to pass away. And so some of these things that we’ve been asking them to do, when can we soften that a little bit?” And that’s a really complicated dance. 

    And if there’s a way that, as a scientist, I can say, “This is one model that we tested and it seemed to help, in terms of how people experience their care, or how their loved ones felt that the quality of their dying process was better,” then that’s worth doing. 

    Can you explain to me a little bit about your Cumulative Complexity Model?

    It started when I was doing work with colleagues at the time at the University of Minnesota who had some interesting data on people who used different public insurance programs — typically, low-income people in Medicaid and other state programs in Minnesota. …And at the same time, I was looking at what I would call fairly typical Mayo Clinic patients, meaning people who had a lot of health problems, but not necessarily as many of the types of social problems and social service needs that people in those public insurance programs needed. 

    They’re two really different populations, so what’s the common thread? And I was looking at both of the groups and I realized, if you step back a little bit and go a little bit more abstract, they both face these challenges. The challenge comes from the fact that there is a lot of potential work to do, both in being a patient and also in your life. 

    On the other hand, there are people who can handle a lot of work and they’re okay, they don’t get stressed out, they’re fine. They don’t fail. They don’t forget. They are able to do it. So there’s some other factor. Everybody has a finite amount of capacity to bring to bear. If work, generally, can be summed up as anything that takes up time, energy or attention, then capacity is anything that affects your readiness, motivation and ability to carry out tasks or to do work.

    How does that translate to health care? 

    A classic example of a breakdown in the balance between work and capacity would be a missed appointment. Now, maybe that’s because you forgot and you don’t have enough redundancies or somebody around you to help remind you; maybe you missed it because you were really, really depressed that day and you just couldn’t get to moving to do much of anything. Or you didn’t take a medication when you were supposed to. There’s a task set for you and, for whatever reason, you didn’t have the readiness, the motivation or the ability to do it. 

    That reminds me of Christine Miserandino’s “spoon theory,” this concept that people living with chronic illnesses have a set number of “spoons” (energy, ability) per day, and they have to be judicious in how they use them. 

    I don’t know if [the spoon theory] was around at the time that we did this; it was fairly young. They’re really kind of complementary ideas. It’s funny because for people who know the model, we would even use the language of the model just to say how we’re doing. 

    One of the things to keep in mind is that there were models or approaches to patient complexity before. And what I wanted to do with this was to make a functional model. So it’s an ongoing thing, which feels more like living — where that interaction between those things then affects how you access and use care and how you carry out your own self-care, and then that in turn is going to affect your outcomes. 

    We hear so much about how people’s experiences within a health care system vary so much depending on their identities — race, gender, disability, etc. How does that factor into this work? Do complexity models inherently acknowledge intersectionality? 

    I don’t think it’s ever naturally incorporated. That’s why we always have to be intentional. Back in 1971, a Welsh general practitioner named Julian Tudor Hart came up with this thing that he called the inverse care law, which is that the availability of quality medical care is inversely proportional to the need of the population it serves. So the people who often need care the most have the hardest time getting it. [Cesar Gomes Victora and colleagues] later on came up with the inverse equity hypothesis, and it’s the idea that any new intervention, any new improvement, any new program that we introduce, it’s going to benefit the most privileged first and most. 

    If you just develop a program and don’t think about that and don’t build that in, I think you’re just going to end up potentially widening the disparities in outcomes, not because you’re hurting anybody, but because you’re actually just benefiting more the people who already are doing pretty well. 

    This article was supported by a grant from Bloomberg Philanthropies.

    Adblock test (Why?)


    Researcher studying life's complexities to improve chronic disease care - STAT
    Read More

    The Winnipeg Foundation Innovation Fund supports cutting-edge projects - UM Today

    February 1, 2024 —  Three interdisciplinary teams from the Rady Faculty of Health Sciences have received $100,000 grants from The Winnipeg...